Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 16 studies | 30% ± 13% | |
peripheral blood | 16 studies | 28% ± 7% | |
intestine | 9 studies | 23% ± 10% | |
kidney | 8 studies | 30% ± 4% | |
liver | 5 studies | 28% ± 15% | |
pancreas | 4 studies | 34% ± 11% | |
bone marrow | 4 studies | 23% ± 3% | |
uterus | 4 studies | 29% ± 15% | |
lymph node | 4 studies | 30% ± 17% | |
breast | 4 studies | 21% ± 4% | |
placenta | 3 studies | 42% ± 11% | |
adrenal gland | 3 studies | 20% ± 4% | |
thymus | 3 studies | 35% ± 13% | |
brain | 3 studies | 27% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2162.30 | 1445 / 1445 | 100% | 100.20 | 183 / 183 |
kidney | 100% | 3371.90 | 89 / 89 | 100% | 163.13 | 901 / 901 |
liver | 100% | 1964.07 | 226 / 226 | 100% | 181.36 | 406 / 406 |
ovary | 100% | 1895.46 | 180 / 180 | 100% | 211.79 | 430 / 430 |
pancreas | 100% | 1935.20 | 328 / 328 | 100% | 141.93 | 178 / 178 |
skin | 100% | 2302.63 | 1809 / 1809 | 100% | 144.36 | 472 / 472 |
thymus | 100% | 2277.18 | 653 / 653 | 100% | 204.94 | 605 / 605 |
uterus | 100% | 2028.88 | 170 / 170 | 100% | 185.87 | 459 / 459 |
brain | 100% | 1836.97 | 2640 / 2642 | 100% | 131.73 | 705 / 705 |
prostate | 100% | 2546.41 | 245 / 245 | 100% | 160.95 | 501 / 502 |
lung | 100% | 2573.13 | 578 / 578 | 100% | 178.09 | 1152 / 1155 |
breast | 100% | 2424.82 | 459 / 459 | 100% | 171.86 | 1114 / 1118 |
intestine | 100% | 2062.60 | 966 / 966 | 100% | 128.95 | 525 / 527 |
adrenal gland | 100% | 2823.91 | 258 / 258 | 100% | 117.54 | 229 / 230 |
stomach | 100% | 2014.58 | 359 / 359 | 99% | 117.18 | 284 / 286 |
bladder | 100% | 2420.10 | 21 / 21 | 99% | 180.80 | 500 / 504 |
adipose | 100% | 2362.81 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2619.80 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 121.17 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 245.35 | 29 / 29 |
spleen | 100% | 2232.04 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 157.95 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 94.48 | 1 / 1 |
muscle | 100% | 2124.36 | 800 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 2591.47 | 923 / 929 | 0% | 0 | 0 / 0 |
heart | 99% | 1926.79 | 851 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051865 | Biological process | protein autoubiquitination |
GO_0016567 | Biological process | protein ubiquitination |
GO_0005737 | Cellular component | cytoplasm |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | RNF181 |
Protein name | Alternative protein RNF181 Ring finger protein 181 E3 ubiquitin-protein ligase RNF181 (EC 2.3.2.27) (RING finger protein 181) |
Synonyms | HSPC238 |
Description | FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates . Catalyzes monoubiquitination of 26S proteasome subunit PSMC2/RPT1 . . |
Accessions | H7C426 C9J391 Q9P0P0 ENST00000306368.9 ENST00000414390.5 ENST00000443647.5 L8EAW4 F8WBU5 ENST00000456023.1 C9J1C6 ENST00000441634.5 |